UBU5:F:F-UBS (Irl) ETF Public Limited Company - MSCI USA Value UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 97.58

Change

-0.13 (-0.13)%

Market Cap

USD 0.47B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.06 (-0.11%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

+7.42 (+1.34%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 108.41B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.03 (-0.19%)

USD 52.77B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

+1.48 (+1.51%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 46.87B
0ZC:F Zscaler Inc

+6.85 (+2.71%)

USD 37.92B
BSND:F Danone SA

+0.10 (+0.68%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+1.10 (+0.87%)

USD 24.77B

ETFs Containing UBU5:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.77% 19% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.77% 19% F 37% F
Trailing 12 Months  
Capital Gain 1.65% 36% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.65% 35% F 48% F
Trailing 5 Years  
Capital Gain 51.76% 60% D- 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 51.76% 60% D- 47% F
Average Annual (5 Year Horizon)  
Capital Gain 11.71% 78% C+ 70% C-
Dividend Return 11.71% 76% C+ 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.81% 50% F 85% B
Risk Adjusted Return 91.43% 86% B+ 90% A-
Market Capitalization 0.47B 58% F 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.